Radioiodine in Low-Risk Thyroid Cancer | NEJM
1 Lượt xem
• 07/06/23
0
0
Nhúng
administrator
Người đăng ký
Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3HvClQD
Cho xem nhiều hơn
Bình luận trên Facebook
SORT BY-
Nhận xét hàng đầu
-
Bình luận mới nhất